Thyroid function and the metabolic syndrome in older persons: A population-based study

European Journal of Endocrinology

Volumn 168, Issue 1, 2013, Pages 59-65

  Heima, Nathalie E ^a   Eekhoff, E Marelise W ^a   Oosterwerff, Mirjam M ^a   Lips, Paul T A ^a   Van Schoor, Natasja M ^a   Simsek, Suat ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Northwest Clinics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; HIGH DENSITY LIPOPROTEIN; THYROTROPIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG USE; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GENDER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NETHERLANDS; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; NETHERLANDS; THYROTROPIN;

EID: 84871972405     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0375     Document Type: Article

References (38)

1. Lu L, Wang B, Shan Z, Jiang F, Teng X, Chen Y, Lai Y, Wang J, Xue H, Wang S et al. The correlation between thyrotropin and dyslipidemia in a population-based study. Journal of Korean Medical Science 2011 26 243-249. (doi:10.3346/jkms.2011.26.2.243)
2. Liu D, Jiang F, Shan Z, Wang B, Wang J, Lai Y, Chen Y, Li M, Liu H, Li C et al. A cross-sectional survey of relationship between serum TSH level and blood pressure. Journal of Human Hypertension 2009 24 134-138. (doi:10.1038/jhh.2009.44)
3. Asvold BO, Bjoro T, Nilsen TIL & Vatten LJ. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. Journal of Clinical Endocrinology and Metabolism 2007 92 841-845. (doi:10.1210/jc.2006-2208)
4. Asvold BO, Vatten LJ, Nilsen TIL & Bjoro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. European Journal of Endocrinology 2007 156 181-186. (doi:10.1530/eje.1.02333)
5. Lai Y, Wang J, Jiang F, Wang B, Chen Y, Li M, Liu H, Li C, Xue H, Li N et al . The relationship between serum thyrotropin and components of metabolic syndrome. Endocrine Journal 2011 58 23-30. (doi:10.1507/endocrj.K10E-272)
6. Roos A, Bakker SJL, Links TP, Gans ROB & Wolffenbuttel BHR. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. Journal of Clinical Endocrinology and Metabolism 2007 92 491-496. (doi:10.1210/jc.2006-1718)
7. Ruhla S,Weickert MO, Arafat AM, Osterhoff M, Isken F, Spranger J, Schöfl C, Pfeiffer AF & Möhlig M. A high normal TSH is associated with the metabolic syndrome. Clinical Endocrinology 2010 72 696-701. (doi:10.1111/j.1365-2265.2009.03698.x)
8. Park SB, Choi HC & Joo NS. The relation of thyroid function to components of the metabolic syndrome in Korean men and women. Journal of Korean Medical Science 2011 26 540-545. (doi:10.3346/jkms.2011.26.4.540)
9. Lai C-C, Tang S-H, Pei D, Wang C-Y, Chen Y-L, Wu C-Z, Hsiao F-C, Chen H-S & Wang J-Y. The prevalence of subclinical thyroid dysfunction and its association with metabolic syndrome in Taiwanese elderly. International Journal of Gerontology 2011 5 25-29. (doi:10.1016/j.ijge.2011.01.005)
10. Wang JY, Wang CY, Pei D, Lai CC, Chen YL, Wu CZ, Chang YL, Hsu CH, Pei C & Tang SH. Association between thyroid function and metabolic syndrome in elderly subjects. Journal of the American Geriatrics Society 2010 58 1613-1614. (doi:10.1111/j.1532- 5415.2010.02998.x)
11. Waring AC, Rodondi N, Harrison S, Kanaya AM, Simonsick EM, Miljkovic I, Satterfield S, Newman AB & Bauer DC. Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study. Clinical Endocrinology 2012 76 911-918. (doi:10.1111/j.1365- 2265.2011.04328.x)
12. Cooper DS & Biondi B. Subclinical thyroid disease. Lancet 2012 379 1142-1154. (doi:10.1016/S0140-6736(11)60276-6)
13. Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clinical Chemistry 1987 33 2153-2163.
14. Al-Delaimy WK, Jansen EH, Peeters PH, van der Laan JD, van Noord PA, Boshuizen HC, van der Schouw YT, Jenab M, Ferrari P & Bueno-de-Mesquita HB. Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 2006 11 370-382. (doi:10.1080/13547500600799748)
15. Herdzik E, Safranow K & Ciechanowski K. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test. Acta Diabetologia 2002 39 15-22. (doi:10.1007/s005920200007)
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497. (doi:10.1001/jama.285.19.2486)
17. Fernandez ML & Webb D. The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. Journal of the American College of Nutrition 2008 27 1-5. (Pubitemid 351600516)
18. Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, Dagenais GR & Després JP. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Archives of Internal Medicine 2001 161 2685-2692. (doi:10.1001/archinte.161.22.2685)
19. Meigs JB, Wilson PWF, Nathan DM, D'Agostino RB, Williams K & Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003 52 2160-2167. (doi:10.2337/diabetes.52.8.2160)
20. Hildrum B, Mykletun A, Hole T, Midthjell K & Dahl A. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 Study. BMC Public Health 2007 7 220. (doi:10.1186/1471-2458-7-220)
21. Alkerwi A, Boutsen M, Vaillant M, Barre J, Lair ML, Albert A, Guillaume M & Dramaix M. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis 2009 204 624-635. (doi:10.1016/j.atherosclerosis.2008.10.036)
22. Garretsen HFL & Knibbe RA. Alcohol consumption and alcohol control policy: the case of the Netherlands. Health Policy 1985 5 151-158. (doi:10.1016/0168-8510(85)90029-6)
23. Asvold BO, Bjoro T, Nilsen TIL & Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Archives of Internal Medicine 2007 167 1428-1432. (doi:10.1001/archinte.167.13.1428)
24. Laaksonen DE, Lakka HM, Salonen JT, Niskanen LK, Rauramaa R & Lakka TA. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002 25 1612-1618. (doi:10.2337/diacare.25.9.1612)
25. Solomon TPJ, Sistrun SN, Krishnan RK, Del Aguila LF, Marchetti CM, O'Carroll SM, O'Leary VB & Kirwan JP. Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults. Journal of Applied Physiology 2008 104 1313-1319. (doi:10.1152/japplphysiol.00890.2007)
26. Stel VS, Smit JH, Pluijm S, Visser M, Deeg DJH & Lips P. Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. Journal of Clinical Epidemiology 2004 57 252-258. (doi:10.1016/j.jclinepi.2003. 07.008)
27. Rotondi M, Leporati P, La Manna A, Pirali B, Mondello T, Fonte R, Magri F & Chiovato L. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? European Journal of Endocrinology 2009 160 403-408. (doi:10.1530/EJE-08-0734)
28. Cappelli C, Rotondi M, Pirola I, Agosti B, Gandossi E, Valentini U, De Martino E, Cimino A, Chiovato L, Agabiti-Rosei E et al . TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care 2009 32 1589-1590. (doi:10.2337/dc09-0273)
29. Tan KC, Shiu SW & Kung AW. Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein. Journal of Clinical Endocrinology and Metabolism 1998 83 2921-2924. (doi:10.1210/jc.83.8.2921)
30. Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, Alevizaki M, Mitrou P, Lambadiari V, Boutati E, Nikzas D et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. European Journal of Endocrinology 2009 160 785-790. (doi:10.1530/EJE-08-0797)
31. Maratou E, Hadjidakis DJ, Peppa M, Alevizaki M, Tsegka K, Lambadiari V, Mitrou P, Boutati E, Kollias A, Economopoulos T et al. Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. European Journal of Endocrinology 2010 163 625-630. (doi:10.1530/EJE-10-0246)
32. Parle JV, Maisonneuve P, Sheppard MC, Boyle P & Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001 358 861-865. (doi:10.1016/S0140-6736 (01)06067-6)
33. Gussekloo J, van Exel E, de Craen AJM, Meinders AE, Frölich M & Westendorp RGJ. Thyroid status, disability and cognitive function, and survival in old age. Journal of the American Medical Association 2004 292 2591-2599. (doi:10.1001/jama.292.21.2591)
34. Vischer UM, Safar ME, Safar H, Iaria P, Le Dudal K, Henry O, Herrmann FR, Ducimetière P & Blacher J. Cardiometabolic determinants of mortality in a geriatric population: is there a "reverse metabolic syndrome"? Diabetes & Metabolism 2009 35 108-114. (doi:10.1016/j.diabet.2008.08.006)
35. Weverling-Rijnsburger AWE, Jonkers IJAM, van Exel E, Gussekloo J & Westendorp RGJ. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Archives of Internal Medicine 2003 163 1549-1554. (doi:10.1001/archinte.163.13.1549)
36. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies Lancet 2007 371 1927-1935. (doi:10.1016/S0140-6736(08)60602-9)
37. de Jongh RT, Lips P, van Schoor NM, Rijs KJ, Deeg DJ, Comijs HC, Kramer MH, Vandenbroucke JP & Dekkers OM. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. European Journal of Endocrinology 2011 165 545-554. (doi:10.1530/EJE-11-0430)
38. van de Ven AC, Netea-Maier RT, Medici M, Sweep FC, Ross HA, Hofman A, de Graaf J, Kiemeney LA, Hermus AR, Peeters RP et al. Underestimation of effect of thyroid function parameters on morbidity and mortality due to intra-individual variation. Journal of Clinical Endocrinology and Metabolism 2011 96 E2014-E2017. (doi:10.1210/jc.2011-0680)